Xarelto Lawsuits on the Rise in Tennessee; Link Drug With Risk of Internal Bleeding Injuries

A Tennessee resident has filed a wrongful death lawsuit in the Xarelto multidistrict litigation over his father’s death, allegedly due to complications from the use of the anticoagulant. The complainant alleges that his father died from an uncontrollable, irreversible internal bleeding event as a result of Xarelto side effects. Accusing drug manufacturers Bayer AG and Janssen Pharmaceuticals of failure to warn patients of the potential Xarelto bleeding side effects, the lawsuit claims that the deceased was prescribed the blood thinner to treat atrial fibrillation symptoms and prevent the risk of blood clots and stroke.

The plaintiff accuses the drug makers of intentionally misleading the medical community about the serious threats posed by the anticoagulant, which is unreasonably dangerous and defective. Introduced in the market in 2011, Xarelto claims to be a one-size-fits-all medication for deep vein thrombosis, strokes, and pulmonary embolism in patients suffering from atrial fibrillation.

Unfortunately, unlike other anticoagulants, Xarelto blood thinner does not respond to fresh frozen plasma and Vitamin K treatment, which is given as an antidote to allow the patient’s blood to clot in the event of internal bleeding. As a result, the use of Xarelto causes an unstoppable, fatal event of internal bleeding for the patient.

The complaint indicates that Xarelto’s dangerous lack of antidote raises the risk of potentially fatal gastrointestinal bleeding episodes. The lawsuit accuses defendants Bayer and Janssen of pushing direct-to-consumer advertising, claiming that Xarelto was safer than other blood thinners and also required less monitoring and doctor visits, and failing to adequately warn about that its lack of reversal agent or antidote to counteract the drug complications.

The Xarelto injury lawsuit accuses Bayer and Janssen of wrongful death, fraudulent misrepresentation, negligent misrepresentation, strict products liability, negligence, breach of implied and express warranty, fraudulent concealment, and fraud and deceit.

Xarelto Side Effects

Abdominal bleeding
Eye bleeding
Deep vein thrombosis
Gastrointestinal bleeding
Pulmonary embolism
Reduced platelet levels
Abnormal liver function
Brain hemorrhaging
Rectal bleeding
Dizziness
Low blood pressure
Hemorrhaging in the eyes
Nose bleeding
Muscle pain
Headache
Rapid heartbeat
Edema
Bruising

Other Xarelto Lawsuits

A Tennessee family filed a Xarelto lawsuit against Janssen, a Johnson & Johnson subsidiary, on August 14, 2014, seeking $10 million in damages for pain, suffering, personal injuries, wrongful death, and emotional distress. The claimants claim that their father died from the Xarelto complications, suffering irreversible internal bleeding and “was caused to sustain severe and permanent personal injuries, pain, suffering, and emotional distress.”

The ever-growing number of Xarelto side effect lawsuits indicates that the drug was rushed to the market without adequate testing and brazenly promoted without warning of its fatal risks. Lawsuits accuse the drug manufacturers of promoting Xarelto blood thinner as an easy to use and monitor anticoagulant.

Different studies claim that Xarelto side effects may lead to eye bleeding. spontaneous vitreous hemorrhage, stomach or gastrointestinal bleeding.

If you or a loved one has suffered from the drug side effects, you have a potential Xarelto lawsuit arising out of “negligence, concealing of information, misrepresentation, and false advertisement by the manufacturer. Please contact us or call on 1-800-632-1404 for a free consultation with our experienced Xarelto attorney.

October 24, 2015October 24, 2015

Xarelto Bleeding Injury Help

Xarelto is a specific type of Factor Xa inhibitor anticoagulant that has been on the market since the U.S. Food and Drug Administration (FDA) approved its use in 2011. The pharmaceutical company Bayer created the medication, and licensed the right to manufacture and market it to Johnson and Johnson affiliate Janssen.

Besides arthroplasty patients, Xarelto is prescribed to atrial fibrillation patients to help prevent strokes and other dangerous events that might result from blood clots, such as pulmonary embolism and heart attacks.

Unfortunately, Xarelto can at the same time produce a risk of serious internal bleeding, including hemorrhagic stroke, brain hemorrhage, and gastrointestinal bleeding. Some have referred to these injuries as an Xarelto Bleeding Injury.

In 2014, the U.S. FDA approved additional language for Xarelto’s package labeling to warn about some but not all of the risks of bleeding events, including discouraging use of the drug in some kidney patients, pregnant women, nursing mothers, and patients with heart valves. However, the label does not warn about wound infection risks or the lack of an antidote in the event of a hemorrhage.

To discuss a Xarelto Bleeding injury or other event, please call us at (800) 632-1404 or chat with us today.

October 16, 2015

Arkansas Xarelto Injury Lawsuit: Latest Developments To Know

An Arkansas Xarelto injury lawsuit filed by the family of a deceased woman blames an irreversible brain hemorrhage associated with the blood thinner for her death. The woman, a nursing home resident, fell and injured her head. She was given first aid and her doctor was called next morning, as her condition worsened. The resident died following a massive cerebral bleeding. She was treated with Xarelto, a blood thinner known to cause internal bleeding and without a known antidote.

The Arkansas Xarelto attorney fighting for the plaintiff claims that doctors could not prevent bleeding effects of the anticoagulant for the lack of any reliable reversal agent. Bayer and Johnson & Johnson are facing product liability claim for marketing a dangerous drug with irremediable side effects. The case is a warning for one in every six nursing home residents and millions other taking anticoagulants. Introduction of new-generation blood thinners, such as Pradaxa and Xarelto, without antidotes put them at the increased risk of uncontrolled gastrointestinal, brain, and stomach bleeding and strokes.

The following are important developments to know for anyone considering filing a Xarelto injury lawsuit in Arkansas.

Xarelto Not Safer, Warn Researchers

A recent report citing a French research paper concludes that Xarelto is not superior to warfarin. Published in the American Heart Association journal Circulation, it says that the new anticoagulant holds similar “short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients” as the old blood thinner warfarin. However, it is the lack of antidote that makes Xarelto bleeding side effects more fatal.

According to the Journal for the American Medical Association, Xarelto is too dangerous for kidney patients. It quoted combined guidelines of “the American College of Cardiology, the American Heart Association, and the Society of Thoracic Surgeons” to highlight how new anticoagulants are hazardous for end-stage chronic kidney patients.

Xarelto Lawsuits on the Rise

The second quarter report of Bayer published in July 2015 admits of defending against 1,200 Xarelto bleeding lawsuits. The drug maker faces at least six class actions in Canada. This count excludes about many claims filed against Bayer and Johnson & Johnson in the last one month. Eastern Louisiana federal Judge Eldon Fallon is designated for consolidation of all Xarelto injury lawsuits under the federal MDL provision.

On August 3, four litigations representing 198 claimants joined the MDL claiming wrongful death and injuries attributed to bleeding side effects of the drug.

Statistics Against Xarelto

A study has revealed that 73 percent of persons suffered from side effects during the testing of Xarelto. Reports indicate that “the Einstein studies, the Record studies, and the Rocket AF study” highlighted uncontrolled bleeding risk during the trail phase. But the information was not disclosed to the public and the anticoagulant was promoted as safe.

At least 400 deaths and 3,500 hospitalizations involving Xarelto have been reported since it was approved in 2011. With a surge in prescriptions, the reports of adverse events are on the rise. The drug was responsible for 72 deaths and 896 hemorrhage reports in Germany in 2013. The Institute for Safe Medication Practices included it among the 10 most-frequent side effect reported drugs in 2014.

According to a Milwaukee Journal investigative report, Pradaxa, Xarelto, and Eliquis – three new-generation blood thinners – accounted for 8,000 deaths and 58,000 bleeding injuries in the last four years compared to 700 deaths and 8,000 injures linked to warfarin.

Three-fourths of all Xarelto bleeding reports cite intracerebral hemorrhage, claims the Journal of the American College of Cardiology. The FDA has also warned of blood clots in patients who stop taking the drug abruptly.

Past History of Drug Makers Questionable

The past history of Xarelto makers Bayer and Janssen, a Johnson & Johnson unit, indicates how their defective drugs and suppression of information caused injuries to thousands of users. Janssen settled hundreds of Risperdal lawsuits for $2 billion after plaintiffs accused it of putting profits before people. Bayer is facing over 4,000 Mirena contraceptive injury lawsuits for suppressing safety information. It had settled 9,900 Yasmin and Yaz lawsuits while another 4,000 are awaiting trial. These incidents indicate how both companies give primacy to commercial profit over user safety and suppress data about drug side effects.

Trial Date Set for Aug 2016

The first Xarelto injury lawsuit seeking product liability was filed in January 2014. Within 18 months, over 1,400 claims have been made and a mass tort has also been established. The first bellwether is set for August 1, 2016. It will be followed three more trials on August 22, September 12, and October 17. While the first two will be presided by MDL Judge Eldon Fallon of Eastern district of Louisiana, the other two are slated to be held in Texas and Mississippi federal courts.

If you have a potential Xarelto injury lawsuit in Arkansas (or elsewhere) related to the blood thinner side effects and arising out of “negligence, concealing of information, misrepresentation, and false advertisement by the manufacturer”, please contact us or call on 1-800-632-1404 for a free consultation with our Xarelto attorney.

October 14, 2015October 14, 2015

Xarelto Lawsuit: Claims Get A Boost As Studies Confirm Potential Bleeding Injuries

In a boost to claims by Xarelto lawsuit plaintiffs, two recent studies have confirmed close association between the blood thinner and bleeding injuries. The new-generation anticoagulant was approved by the FDA in 2011. However, it has been blamed for over 500 deaths and more than 4,500 hospitalizations in the last four years. Nearly 1,500 victims of gastrointestinal, cerebral, and other types of irreversible bleeding have sought product liability by filing a Xarelto lawsuit against manufacturers Bayer and Janssen, a Johnson & Johnson subsidiary.

Study Links Xarelto to Eye Bleeding

A study published in the JAMA Ophthalmology journal in June 2015 claims that Xarelto adverse events may lead to eye bleeding. Researchers from Los Angeles-based Keck School of Medicine Eye Institute discovered that “the risk of hemorrhage may be particularly elevated during the transition period when patients are switched from baseline anticoagulant to rivaroxaban (generic name of Xarelto) and are taking both anticoagulants simultaneously.”

The study also alleged that at least three users reported spontaneous vitreous hemorrhage following treatment with Xarelto blood thinner. Previous studies had cited that though anticoagulants were not directly responsible for causing eye bleeding, these drugs might increase bleeding due to other pathology. But the recent study discovered occurrence of “bleeding between the lens and retina of the eye.”

Xarelto May Cause Stomach Bleeding

An April 2015 report in the British Medical Journal highlighted the risk of stomach bleeding due to Xarelto blood thinner side effects. This finding based on comparative safety data analysis reinforces claims of hundreds of Xarelto lawsuits alleging gastrointestinal hemorrhage.

Researchers analyzed case studies of 46,000 patients – 39,607 treated with warfarin, 1,649 prescribed Xarelto, and others given Pradaxa – treated with blood thinners between October 1, 2010 and March 31, 2012. Pradaxa is already in the thick of litigation due to its bleeding side effects and fatal injuries. Its manufacturer paid $650 million to settle about 4,000 claims.

The study pointed “as much as a 50% increase in the risk of gastrointestinal bleeding with dabigatran (Pradaxa) compared with warfarin or a more than twofold higher risk of bleeding with rivaroxaban (Xarelto) compared with warfarin.” Until now the makers of Xarelto blood thinner were claiming that their product was safe and without any bleeding effect. But the findings proved otherwise lending credence to claim of hundreds of patients who had fatal and non-fatal stomach bleeding following the drug therapy.

Bleeding Side Effect Claims

Xarelto was approved in 2011 and its popularity is primarily driven by the manufacturer claim that the drug is more convenient and patients need not be monitored for potential bleeding effects. If post-marketing surveys and consumer complaints are to be believed, the blood thinner has proved to be more dangerous than warfarin. Patients above 65 years of age are found to have suffered maximum due to Xarelto bleeding side effects. A 2015 Japanese study claims that 29 of 46 patients treated with the blood thinner are reported for heightened bleeding risks.

If you have a potential Xarelto injury lawsuit related to the blood thinner side effects and arising out of “negligence, concealing of information, misrepresentation, and false advertisement by the manufacturer”, please contact us or call on 1-800-632-1404 for a free consultation with our experienced Xarelto attorney.

September 15, 2015

Xarelto Injury Lawsuits Mount, Study Rejects Anticoagulant Benefits

A Xarelto injury lawsuit filed by a Tennessee family a few weeks ago has sought financial damages from the makers of the blood thinner citing the wrongful death of a patient. The litigation alleges that Bayer and Johnson & Johnson merely “indicated that there was a risk for bleeding and continue selling the drug side-stepping the important issue of reversing the effects of Xarelto should a bleed occur.” The claim is among nearly 1,300 such drug injury lawsuits filed against Bayer in Canada and the United States.

The deceased was prescribed the anticoagulant to treat the risk of heart stroke from non-valvular atrial fibrillation. He died within six months following internal bleeding. According to the Tennessee Xarelto attorney representing the plaintiff, manufacturers have failed to address the issue of irreversible hemorrhaging associated the drug and their claim of superiority of the drug over other anticoagulants is misleading.

Xarelto makers promoted the drug as superior to the long-used blood thinner warfarin. While bleeding caused by warfarin is stopped with vitamin K shots, there is no cure for Xarelto bleeding side effects turn serious and fatal to cause hemorrhage and death. The Institute for Safe Medication Practices claims the blood thinner is the most frequent cause of pulmonary embolism in users. It also found that 44 percent Xarelto complaints reported involve users with hip and knee replacement surgery.

198 Plaintiffs Join Xarelto Litigation

On August 3, four lawsuits representing over 198 Xarelto bleeding side effects were added to the MDL centralized at an Eastern Louisiana federal court. These claimants are unanimous that the anticoagulant led to fatal or near-fatal injuries and deaths. Many of these claims include wrongful death following irreversible bleeding.

The four bundled claims, as presented by Xarelto lawyers, highlight internal bleeding-related side effects, such as

gastrointestinal bleeding
bleeding symptoms visible in urine
brain hemorrhaging
subdural hematoma
pulmonary embolism
bleeding in intestine and kidney
irreversible bleeding
hemoglobin level drop

Study Flays Xarelto Benefit Claims

A study recently reported by Circulation journal of the American Heart Association rejects safety claims by Xarelto manufacturers when compared to warfarin. Researchers discovered that the new-generation blood thinner has no advantage over warfarin as far as “short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients” is concerned.

Based on the French monitoring over 32,000 patients treated with Xarelto, Pradaxa, and warfarin over a period, the study mentions “no significant difference in the rate of bleeding events or arterial thromboembolic events.” It warns that though there is no higher bleeding risk from Xarelto, the absence of a reliable antidote makes bleeding events irreversible and fatal. Doctors struggle to stop bleeding as they are unaware of any effective and approved reversal agent. Longer the internal bleeding, greater is the risk of patient’s death.

An April 2015 study reported by the British Medical Journal cited findings of Johns Hopkins University School of Medicine team to highlight “two-time higher risk” of internal bleeding in patients being treated with Xarelto.

If you have a potential Xarelto injury lawsuit in Tennessee related to the blood thinner side effects and arising out of “negligence, concealing of information, misrepresentation, and false advertisement by the manufacturer”, please contact us or call on 1-800-632-1404 for a free consultation with our experienced Xarelto attorney.

July 19, 2015

Xarelto Injury: New Study Claims Two-Fold Higher Bleeding Risk Than Warfarin

Dismissing manufacturer’s safety claims, a new Xarelto injury study has warned of greater threat of gastrointestinal bleeding associated with the blood thinner compared to warfarin. Published on 24 April 2015 in the British Medical Journal, the study carried on by scholars from the Johns Hopkins University School of Medicine discovered that Xarelto bleeding injury risk is two-time higher than old blood thinner warfarin while Pradaxa, another infamous blood thinner that led to more than 4,000 lawsuits and $650 million carries 50% more risk .

In 2012, Reuters reported concerns expressed by many top cardiologists over potential Xarelto injury risks. This was attested by the MedWatch data revealing 151 deaths and over 2,000 hospitalizations associated with Xarelto bleeding side effects in 2012. In the first 150 days of 2013, 200 died and about 700 were treated for internal hemorrhage.

The Johns Hopkins Study Report

The study looked in to the case history of over 46,000 patients treated with Xarelto, Pradaxa, or warfarin. All patients used these drugs from October 2010 to March 2012. It was found that “rates of gastrointestinal bleeding seem to be similar in this commercially insured sample of adults though it cannot be ruled out that as much as a 50% increase in the risk of gastrointestinal bleeding with dabigatran (Pradaxa) compared with warfarin and a more than twofold higher risk of bleeding with rivaroxaban (Xarelto) compared with warfarin.

Though the researchers admit that statistical demonstration is not significant for the purpose of comparison of bleeding risk associated with these drugs, they concede that age is a factor and Xarelto and Pradaxa carry higher injury risk than warfarin.

Warfarin has been prescribed for decades prior to Xarelto and Pradaxa were introduced. Xarelto manufacturer Bayer advertised the drug as a new-generation blood thinner considerably reducing the frequency of blood monitoring. However, thousands of reports and more than 500 Xarelto lawsuits indicate a different story. There have been deaths and hospitalizations due to severe and uncontrolled bleeding associated with the blood thinner.

The absence of any reversal agent to counter Xarelto side effects makes bleeding uncontrollable. This makes the condition of the patients fatal in the absence of inadequate monitoring.

Xarelto Bleeding Research Studies

A Japanese study published in The Journal of Cardiology observed that “the drug caused a prolonged ‘thinning’ effect, making patients more likely to experience serious bleeding events within two weeks” during a trial compared to warfarin. Researchers also emphasized on the need for “monitoring of patients treated with Xarelto for potential bleeding effects and hemorrhage.” The manufacturer claims the superiority of Xarelto over warfarin on the ground that it does not necessitate monitoring for bleeding effects. Another February 2015 also criticized the claim and warned of fatal consequences unless patients are monitored for hemorrhage risk. Xarelto injury may also impact the kidney. According to Journal of the American College of Cardiology, the blood thinner may lead to brain, stomach, and intestine hemorrhages.

The American Heart Association acknowledged a report in 2013 that warned of three-fold rise in Xarelto bleeding injury. The risk goes up by four times for people suffering from Acute Coronary Syndrome. A recent study by researchers from California has cautioned against administering blood thinners to patients with reduced heart rhythm as this increases the bleeding risk.

If you have a potential Xarelto injury claim related to the blood thinner side effects, please contact us or call on 1-800-632-1404 for a free consultation with our Xarelto attorneys today.

May 21, 2015

Xarelto Lawsuit: Judge Calls for “Science Day”

FREE CASE EVALUATION: 1-800-632-1404

With the Xarelto lawsuit MDL fast expanding, the presiding judge has scheduled a “science day” to allow both plaintiffs and defendants to present medical and scientific information supporting their claims. June 11, 2015, has been set as the date for Xarelto lawyers representing more than 400 plaintiffs to present scientific evidence regarding the hemorrhage events the anticoagulant drug reportedly caused. Over 400 deaths and 3,000 injuries linked to Xarelto bleeding side effect have been reported since the drug was approved in July 2011.

The order issued by Judge Eldon Fallon is line with complex prescription drug litigations with present and potential claimants running into big numbers. At least 400 Xarelto lawsuits are part of the MDL and the number is going to expand manifold. Xarelto attorneys in Arkansas, Tennessee, Kentucky, Pennsylvania, Louisiana, and other states are busy evaluating thousands of such product liability claims. One of the latest lawsuits filed on March 31 seeks compensation on the ground of “product liability, intentional and negligent infliction of emotional distress, common law fraud, negligent and fraudulent misrepresentation and breach of warranty.”

“The manufacturer overstated the efficacy of the drug, misleading consumers and failed to fully research Xarelto’s safety or provide adequate instructions, disclosures, and warnings, and knowingly concealed its defects from the public,” according to the Xarelto attorney representing the victim. A large number of similar claims being evaluated by our Arkansas Xarelto attorney for prospective litigation filing.

During the scientific depositions, the court is expected to allow plaintiffs to appraise the court about the risk of irreversible Xarelto internal bleeding the medication causes. Defendants, Bayer and Janssen, are likely to ask about efficacy, side effects, reversal medications, and role of the anticoagulant in treating clotting disorders. A Xarelto mass tort has been established in a Pennsylvania state court, where at least 170 lawsuits are pending for trial.

Evidence Suggesting Irreversible Xarelto Bleeding Side Effects

The rising numbers of claims and research studies have exposed the hollow claims of Bayer and Janssen about the safety and efficacy of the blood thinner. With thousands suffering from side effects, attorneys evaluating Xarelto hemorrhage claims have found that the drug is no way superior from warfarin and seems to be following the ill-fated Pradaxa blood thinner, which was named in more than 4,000 product liability litigations. Boehringer Ingelheim had to compensate Pradaxa victims with $650 million damage payment.

When Xarelto was introduced, the manufacturer advertised it as better than all existing blood thinners. This entices more and more patients to shift to the new medication expecting improved results. However, the lack of reversal agent for the drug makes the drug side effects fatal and over 200 deaths occurred in the first half of 2013. It is listed as the one of the 10 most reported drugs for side effects in a list prepared by the Institute for Safe Medication Practices.

The Journal of Cardiology published a report by Japanese scholars that compared Xarelto with Warfarin. Researchers noticed that “the drug caused a prolonged “thinning” effect, making them more likely to experience serious bleeding events within two weeks” compared to Warfarin. The study advised monitoring of patients treated with Xarelto for potential bleeding effects and hemorrhage.

According to a 2013 report attested by the American Heart Association, Xarelto blood thinner enhances the risk of hemorrhage events by three times. Those with preexisting Acute Coronary Syndrome are four-time increased risk.

If you have a potential claim related to the blood thinner side effects, please contact us or call on 1-800-632-1404 for a free consultation with our experienced Xarelto attorney in Arkansas.

Contact a Xarelto Injury Lawyer Today.

If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.

For a Free Case Evaluation:

TOLL FREE: 1-800-632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

April 22, 2015

Arkansas Xarelto Attorney Answers Xarelto Lawsuit FAQs

FREE CASE EVALUATION: 1-800-632-1404

Who can file a Xarelto lawsuit in Arkansas?

Patients suffered from internal bleeding and associated adverse events following the use of the blood thinner can consult any Arkansas Xarelto attorney to make a product liability claim. Their family members can also file Xarelto lawsuits on behalf of patients seeking damages.

Why there are Xarelto lawsuits?

The fatal and non-fatal events caused by the blood thinner, including brain, stomach, intestine, and gastrointestinal bleedings, have led to filing of Xarelto lawsuits. The anticoagulant is listed among “10 most reported drugs with side effects” last year, claims a report by the Institute for Safe Medication Practices. The Journal of Cardiology has also made similar observations regarding the internal bleeding risk caused by the drug.

Arkansas Xarelto lawyers expect a huge increase in the number of lawsuits as the drug is reported for causing over 3,000 serious injuries and more than 400 deaths in the last three years.

What are most reported Xarelto injuries?

Death due to irreversible internal bleeding
Brain hemorrhage
Gastrointestinal bleeding
Stomach and adrenal bleeding
Intracranial hematoma and swelling
Subarachnoid, subdural, and extradural hemorrhages
Stroke

What is Xarelto blood thinner? Why is it prescribed?

Xarelto is an anticoagulant, commonly known as blood thinner. It contains rivaroxaban, which “interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade” and prevents the clotting of blood. Patients at the risk of blood clotting due to atrial fibrillation, knee surgery, or other disorders are treated with Xarelto to prevent stroke.

Who makes Xarelto? When it was introduced?

Bayer is the manufacturer of Xarelto. It is also marketed by Janssen. The FDA approved the blood thinner in 2011.

What are most important Xarelto bleeding side effect studies?

A 2013 study reported internal bleeding impacting brain, stomach, and intestine are side effects of the Xarelto blood thinner. (Journal of the American College of Cardiology)
Three-fold increase in internal bleeding risk and patients suffering from Acute Coronary Syndrome at four-fold higher risk. (American Heart Association, 2013)
Xarelto was associated with 72 deaths and 896 internal bleeding injuries in Germany in 2013. (Der Spiegel newsmagazine)
A 2011 clinical study discovered two-time higher threat of internal bleedings in patients. (MAGELLAN Phase 3 trial)

What are the damages Arkansas Xarelto injury victims can claim?

A Xarelto lawsuit filed in Arkansas can seek a variety of damages, including

recovery of medical costs, past and future
financial damages, such as loss of wage, costs incurred
compensatory damages for suffering and non-financial losses
punitive damages

An Arkansas Xarelto attorney is an asset for you with greater chance of winning higher compensation either through settlement or trial.

Who should I sue for Xarelto bleeding injury?

Selling defective drugs or not disclosing potential harm associated with its ingestion, make both manufacturer Bayer and distributor Janssen liable for Xarelto product liability lawsuit in Arkansas.

Who is most at risk for Xarelto bleeding and hemorrhagic stroke?

Elder patients and those with preexisting heart ailments are at enhanced risk of Xarelto internal bleeding. The FDA has put a boxed warning citing irreversible bleeding.

What will an Arkansas Xarelto injury lawsuit cost?

We fight drug injury lawsuits on no-obligation or contingency basis. Our Arkansas Xarelto attorney provides free consultation and evaluation and assists plaintiffs in fighting their claim without any upfront legal fee. Clients pay only after we succeed in winning compensation for them.

Is there any blood thinner lawsuit settlement?

Yes. The most famous being the Pradaxa lawsuits alleging internal bleeding injuries and deaths. In 2014, Boehringer Ingelheim paid about $650 million to settle 4,000 blood thinner side effect injury claims.

How much time do I have to file an Arkansas Xarelto lawsuit?

The state has a statute of limitations for filing of personal injury lawsuits. If you have a potential claim related to the blood thinner side effects, please contact us or call on 1-800-632-1404 for a free consultation with our experienced Arkansas Xarelto attorney.

Contact a Xarelto Injury Lawyer Today.

If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.

For a Free Case Evaluation:

TOLL FREE: 1-800-632-1404

EMAIL: click here

FILL OUT THIS FORM:

March 4, 2015

Tennessee Xarelto, Effexor, Testosterone and Zoloft Injuries

The following are the most talked about defective drug lawsuits that dominated medical litigations scenario in 2014 and continue to be in the news in 2015. If you are a Tennessee resident (or from another state), please contact us to see if we can help.

Xarleto Lawsuit

Will Xalerto lawsuit go Pradax way? The blockbuster blood thinner promoted as a safe and secure alternative has been linked to irreversible and uncontrolled internal bleeding. About 200 deaths and 680 adverse events caused by the drug between January and May 2014 make it one of the most reported medications with side effects in 2014. At least 150 patients died and another 2100 suffered injuries following the drug ingestion in 2013.

Over 30 Xalerto lawsuits are pending in the federal court system. A multidistrict litigation has been established in a Louisiana Eastern District court. The number of lawsuits may go into thousands, as Xalerto are evaluating large number of wrongful death and injury claims associated with the anticoagulant.

Over 4,000 Pradaxa lawsuits filed against its maker Boehringer Ingelheim were settled in May 2014 for $650 million. In December 2014, the USMDL ordered pre-trial centralization of two dozens of Xarelto lawsuits filed in 10 different states in the court of Judge Eldon E. Fallon of Louisiana Eastern District.

Testosterone Therapy Lawsuit

In 2015, testosterone therapy lawsuit may emerge as the most talked about defective drug litigation. With millions of consumer using these supplements available in gel, patches, and pills are steadily being educated about heart attack risks and how manufacturers sell them diseases in the name of drugs.

Low-T supplements when used for lifestyle purposes have the potential to cause blood clotting, strokes, heart attack, and even death. Researchers have also linked these sex-boosting hormones to colon cancer, diabetes and metabolic problems, blockages, kidney problems, and liver disorders.

With about 300 lawsuits filed and many in the pipeline, testosterone therapy lawyers expect the litigation to grow in to thousands of Androgel lawsuits, Andrderm lawsuits, Testim lawsuits, Depo-Testosterone lawsuits, Axiron lawsuits, and Testopel lawsuits. The first Androgel lawsuit is expected to go for trial in October 2016, according to the MDL case management order by Illinois Judge Matthew Kennelly.

Zoloft Lawsuit

Zoloft lawyers were busy throughout 2014 evaluating birth defect claims linked to the drug ingestion by pregnant women. This year is expected to keep them busy with further with the steady expansion of the MDL centralized at the court of Judge Cynthia M. Rufe of Pennsylvania.

Zoloft antidepressant, according to plaintiffs and researchers, results in deformities, malformations, and life-threatening disorders in newborns, including

Fatal lung and respiratory problems
Heart defects requiring life-long surgical interventions
Brain and cranial malformations
Spine and neural tube defects
Sever neurological and physical defects

Pfizer, manufacturer of the SSRI antidepressant, has been defending over 500 Zoloft lawsuits seeking product liability for not disclosing the drug’s pregnancy-linked adverse events. Children, as young as three weeks, have undergone open heart surgeries following serious heart attacks caused by prenatal exposure to the drug.

Effexor Lawsuit

The coining of the word “ Effexor Baby” by medical professionals demonstrates how catastrophic are side effects of SSRI and SNRI antidepressants when ingested during pregnancy. The drug, one of the most prescribed drugs, has forced thousands of expectant mothers to rethink over taking antidepressants to save their baby from the impacts of their mental stress and depressive disorders.

Effexor side effects include fatal persistent pulmonary hypertension that causes just-born babies to die of sudden respiratory failure. Hypoplastic heart and other cardiovascular defects not only require surgical interventions at a tender age, but also severe compromise their quality of life. Delayed development, neurological disorders, and limb deformities are also common in such children

At least 100 Effexor lawsuits have been filed in the last six months. The litigation is expected to grow manifold and become one of the most prominent defective drug lawsuits in the coming days.

To know about the process for filing Effexor lawsuit, Zoloft lawsuit, Xalerto lawsuit, Androgel lawsuit or similar defective drug injury claims seeking product liability for drug maker’s actions and inactions, please contact us or call on 1-800-632-1404.

March 4, 2015

Xarelto Lawsuit Numbers Climb, Outnumber Pradaxa

FREE CASE EVALUATION: 1-800-632-1404

A recent Xarelto lawsuit initiated by a Madison woman has sought over $4.35 million in damages and recovery of other costs. Filed in the St. Clair County Circuit Court, it claims that the plaintiff suffered from internal bleeding as the blood thinner “failed to congeal in a timely manner.” Janssen and Bayer Healthcare spent over $10 million to promote Xarelto as a superior alternative to Warfarin, which is contested by many recent studies. The drug earned about $600 million in sales in 2012.

Our firm has filed a lawsuit involving Xarelto and welcomes the opportunity to discuss a new claim with you.

Bernadette Fuller took the drug, like many other victims, to subdue deep vein thrombosis and prevent strokes. However, she became ill after ingesting the drug and had severe internal bleeding that was irreversible in the absence of any Xarelto blood thinner antidote. Her Xarelto attorney accused the manufacturers of hyping the positive research findings without highlighting “the increased risk of gastrointestinal bleeding and bleeding that required transfusion among other serious bleeding concerns.”

Xarelto bleeding side effects result in people with greater chance of hemorrhage risk, according to three studies – “the Einstein studies, the Record studies, the Rocket AF study” – carried out during the clinical trial phase. However, Bayer and Janssen deliberately suppressed the adverse anti-coagulation effects while running promotional campaigns exaggerating the drug effectiveness, which led to injuries and deaths.

The Xarelto blood thinner lawsuit evokes “product liability, intentional infliction of emotional distress, negligent infliction of emotional distress, common law fraud, negligence, negligent misrepresentation, fraudulent misrepresentation and strict products liability” to sue the manufacturers citing personal injuries, medical costs, wage loss, and diminished life following illness.

Xarelto Complaints Outnumber Pradaxa

Xarelto have overtaken Pradaxa both in sales and complaints. The blood thinner accounted for at least 2,081 serious injuries and 151 deaths in 2012. According to the Institute for Safe Medication Practices, the drug was among the “10 most frequently named” medications with adverse events.

In 2014, Xarelto exceeded Pradaxa in number of prescriptions and consequently, the number of complaints eclipsed Pradaxa. A May 2014 ISMP report indicated at least 200 patients died and 680 suffered grievous injuries in the first four months of 2013 following Xarelto bleeding side effects. The figures may go up many times to thousands, as only one-tenth of adverse events were reported to the FDA. The report also warned that Xarelto adverse events were “steadily increasing” with a rise in the use by consumers.

Study Rejects Stated Xarelto Advantage Over Warfarin

A Canadian study has claimed that new generation blood thinner Xarelto is “no safer” that Warfarin oral anti-coagulant, which has been prescribed for over six decades. Published in the Canadian Journal of Cardiology last month, the report was based on an analysis of safety profiles of Pradaxa, Warfarin, and Xarelto blood thinners at Ontario-based Southlake Regional Health Centre.

Researchers found identical safety profiles and side effects of blood thinners while exploring over 900 case studies of users. They found “no significant difference” in bleeding events and action off drugs during the treatment of atrial fibrillation. It blunts the manufacturer claim that Xarelto, which is expensive and with potential more side effects, has an edge over Warfarin.

Xarelto lawsuits filed claim that the drug leads to “uncontrollable bleeding among users” and it become life-threatening in the absence of reversal antidote.

If you have a potential claim related to the blood thinner side effects, please contact us or call on 1-800-632-1404 for a free consultation with our experienced Xarelto attorney.

Contact a Xarelto Injury Lawyer Today.

If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.

For a Free Case Evaluation:

TOLL FREE: 1-800-632-1404

EMAIL: click here

FILL OUT THIS FORM: